看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBITDA Multiple | 12.9x - 14.3x | 13.6x |
| Selected Fwd EBITDA Multiple | 10.1x - 11.1x | 10.6x |
| Fair Value | $16.52 - $18.58 | $17.55 |
| Upside | 17.2% - 31.8% | 24.5% |
| Benchmarks | Ticker | Full Ticker |
| ConvaTec Group PLC | CTEC | LSE:CTEC |
| GE HealthCare Technologies Inc. | 0ADL | LSE:0ADL |
| Medtronic plc | 0Y6X | LSE:0Y6X |
| Zimmer Biomet Holdings, Inc. | ZBH | NYSE:ZBH |
| CONMED Corporation | CNMD | NYSE:CNMD |
| Smith & Nephew plc | SNNU.F | OTCPK:SNNU.F |
| - | - | - |
| Select LTM EBITDA Multiple | |||||||
| Benchmark Companies | |||||||
| CTEC | 0ADL | 0Y6X | ZBH | CNMD | SNNU.F | ||
| LSE:CTEC | LSE:0ADL | LSE:0Y6X | NYSE:ZBH | NYSE:CNMD | OTCPK:SNNU.F | ||
| Historical EBITDA Growth | |||||||
| 5Y CAGR | 6.2% | 5.4% | -0.7% | 1.6% | 7.2% | -1.3% | |
| 3Y CAGR | 9.2% | 1.8% | 3.4% | 6.2% | 9.0% | 3.1% | |
| Latest Twelve Months | 12.6% | 5.4% | 4.4% | 5.4% | 16.2% | 13.5% | |
| Historical EBITDA Profit Margin | |||||||
| 5 Year Average Margin | 21.0% | 17.9% | 27.7% | 31.5% | 16.1% | 21.8% | |
| Prior Fiscal Year | 21.9% | 17.5% | 27.1% | 33.2% | 15.9% | 21.2% | |
| Latest Fiscal Year | 23.1% | 18.3% | 28.0% | 33.7% | 17.6% | 23.0% | |
| Latest Twelve Months | 23.1% | 18.3% | 28.3% | 33.7% | 17.6% | 23.0% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 3.50x | 2.20x | 3.95x | 3.71x | 2.10x | 2.57x | |
| EV / LTM EBITDA | 15.2x | 12.0x | 14.0x | 11.0x | 12.0x | 11.2x | |
| EV / LTM EBIT | 22.9x | 14.3x | 19.5x | 17.9x | 17.2x | 16.8x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBITDA | 11.0x | 12.0x | 15.2x | ||||
| Historical EV / LTM EBITDA | 11.2x | 12.5x | 21.1x | ||||
| Selected EV / LTM EBITDA | 12.9x | 13.6x | 14.3x | ||||
| (x) LTM EBITDA | 1,335 | 1,335 | 1,335 | ||||
| (=) Implied Enterprise Value | 17,242 | 18,150 | 19,057 | ||||
| (-) Non-shareholder Claims * | (2,686) | (2,686) | (2,686) | ||||
| (=) Equity Value | 14,556 | 15,464 | 16,371 | ||||
| (/) Shares Outstanding | 873.5 | 873.5 | 873.5 | ||||
| Implied Value Range | 16.66 | 17.70 | 18.74 | ||||
| FX Rate: USD/USD | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 16.66 | 17.70 | 18.74 | 14.09 | |||
| Upside / (Downside) | 18.2% | 25.6% | 33.0% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | CTEC | 0ADL | 0Y6X | ZBH | CNMD | SNNU.F | |
| Enterprise Value | 7,955 | 43,908 | 130,374 | 28,352 | 2,742 | 14,997 | |
| (+) Cash & Short Term Investments | 65 | 2,873 | 7,922 | 527 | 24 | 619 | |
| (+) Investments & Other | 17 | 373 | 1,262 | 49 | 0 | 16 | |
| (-) Debt | (1,202) | (9,376) | (26,607) | (6,621) | (947) | (3,321) | |
| (-) Other Liabilities | 0 | (206) | (228) | (8) | 0 | 0 | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 6,835 | 37,572 | 112,723 | 22,299 | 1,819 | 12,311 | |
| (/) Shares Outstanding | 2,044.3 | 457.3 | 1,282.5 | 199.1 | 30.9 | 873.5 | |
| Implied Stock Price | 3.34 | 82.16 | 87.89 | 112.02 | 58.85 | 14.09 | |
| FX Conversion Rate to Trading Currency | 1.29 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 2.58 | 82.16 | 87.89 | 112.02 | 58.85 | 14.09 | |
| Trading Currency | GBP | USD | USD | USD | USD | USD | |
| FX Rate to Reporting Currency | 1.29 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |